These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An overview of the direct thrombin inhibitor argatroban. Walenga JM Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():9-14. PubMed ID: 12811006 [TBL] [Abstract][Full Text] [Related]
6. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Dhillon S Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821 [TBL] [Abstract][Full Text] [Related]
7. Argatroban in HIT type II and acute coronary syndrome. Lewis BE; Walenga JM Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():46-55. PubMed ID: 12811012 [TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [TBL] [Abstract][Full Text] [Related]
9. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia. Kondo LM; Wittkowsky AK; Wiggins BS Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409 [TBL] [Abstract][Full Text] [Related]
10. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG; Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723 [TBL] [Abstract][Full Text] [Related]
11. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery. Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959 [TBL] [Abstract][Full Text] [Related]
13. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients. Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186 [TBL] [Abstract][Full Text] [Related]
14. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia. Matthai WH Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153 [TBL] [Abstract][Full Text] [Related]
15. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. LaMonte MP; Brown PM; Hursting MJ Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573 [TBL] [Abstract][Full Text] [Related]
16. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome. Pendleton R; Wheeler MM; Rodgers GM Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Frame JN; Rice L; Bartholomew JR; Whelton A Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Dang CH; Durkalski VL; Nappi JM Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of argatroban. Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469 [TBL] [Abstract][Full Text] [Related]